MRNA
🟢 Moderna is trading 4.09% up today after FDA approval of first mRNA flu vaccine
Moderna is trading 4.09% up now at $63.05 after renewed attention to the FDA’s approval of mFlusiva, its first mRNA-based seasonal flu vaccine.
- Approved for...
